ML 10302

SynDRA canonical compound SYN0053301 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	HTR3A \| HTR3B \| HTR4
Mechanism of action	serotonin receptor partial agonist

All known targets

HTR4

Mechanisms of action (all sources)

HTR4 PARTIAL AGONIST

Cross-references

PubChem CID: 5311299
ChEMBL: CHEMBL286136

Synonyms

2-Piperidinoethyl 4-amino-5-chloro-2-methoxybenzoate
ML10302
2-piperidin-1-ylethyl 4-amino-5-chloro-2-methoxybenzoate
RefChem:89131
2-(piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate
2-(1-Piperidinyl)ethyl 4-amino-5-chloro-2-methoxybenzoate
GTPL235
orb1689243
SCHEMBL2579561
SCHEMBL29386039
BDBM29526
HMS3262O12
Tox21_500795
CCG-222099
LP00795
ML 10302, >=98%, solid
SDCCGSBI-0633756.P001
NCGC00094130-01
NCGC00094130-02
NCGC00094130-03
NCGC00094130-04
NCGC00261480-01
HY-14441
DS-016473
CS-0003360
H37214
T60787
L000650
ML-10302

Look up ML 10302 in the interactive SynDRA portal →